文献速递产科麻醉区域麻醉与超声

初产妇分娩镇痛鞘内布比卡因、左布比卡因和罗哌卡因的剂量-反应曲线

Dose-Response Curves for Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine Given for Labor Analgesia in Nulliparous Women.
PubMed 文献 · Reg Anesth Pain Med · 2017-01-01

该随机对照研究纳入270例初产妇,在宫口扩张≤5 cm时接受鞘内单次注射布比卡因、左布比卡因或罗哌卡因(0.625–6.25 mg,每组15例),以15分钟疼痛评分下降百分比为终点拟合剂量-反应曲线。计算得D50:布比卡因1.56 mg(95%CI 1.25–1.94)、罗哌卡因1.95 mg(1.57–2.43)、左布比卡因2.20 mg(1.76–2.73),支持左布比卡因和罗哌卡因鞘内效能低于布比卡因。

要点

  • 鞘内布比卡因D50为1.56 mg,低于罗哌卡因1.95 mg和左布比卡因2.20 mg。
  • 左布比卡因和罗哌卡因鞘内效能均低于布比卡因。
  • 研究限定初产妇、宫口≤5 cm、未加阿片类药物。

核心结论

  • 鞘内左布比卡因和罗哌卡因的效能低于布比卡因。

研究设计与样本

  • 随机对照研究,纳入270例 requesting neuraxial analgesia 的初产妇,宫口扩张≤5 cm。
  • 每组15例接受0.625、1.0、1.5、2.5、4.0或6.25 mg鞘内单次注射,不加阿片类药物。

主要发现

  • 布比卡因D50为1.56 mg(95%CI 1.25–1.94 mg)。
  • 罗哌卡因D50为1.95 mg(95%CI 1.57–2.43 mg)。
  • 左布比卡因D50为2.20 mg(95%CI 1.76–2.73 mg)。

关键数值与推荐

  • 主要终点为15分钟疼痛评分下降百分比。
  • 采用非线性回归拟合逻辑S形剂量-反应曲线计算D50。

临床怎么用

  • 可为初产妇分娩镇痛鞘内局麻药选择与剂量调整提供效能参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Bupivacaine, levobupivacaine, and ropivacaine are often given intrathecally for labor analgesia, but limited data are available for their dose-response properties in this context. The objective of this study was to describe the dose-response curves of these local anesthetics when given intrathecally for labor analgesia, to determine values for D50 (dose producing a 50% response) and to compare the calculated values of D50 for levobupivacaine and ropivacaine with those for bupivacaine. METHODS: With ethics approval and written consent, we randomized 270 nulliparous laboring patients requesting neuraxial analgesia at 5-cm cervical dilation or less to receive a single dose of intrathecal local anesthetic without opioid as part of a combined spinal-epidural technique. Patients received either bupivacaine, levobupivacaine, or ropivacaine at a dose of 0.625, 1.0, 1.5, 2.5, 4.0, or 6.25 mg (n = 15 per group). Visual analog scale pain scores were measured for 15 minutes, after which further analgesia and management were at the clinician's discretion. The primary end point was percentage reduction of pain score at 15 minutes. Logistic sigmoidal dose-response curves were fitted to the data using nonlinear regression, and D50 values were calculated for each drug. RESULTS: Data were analyzed from 270 patients. Patient characteristics were similar between groups. The calculated D50 and 95% confidence interval values were as follows: bupivacaine, 1.56 mg (1.25-1.94 mg); ropivacaine, 1.95 mg (1.57-2.43 mg); and levobupivacaine, 2.20 mg (1.76-2.73 mg). CONCLUSIONS: The results of this study support previous work showing that intrathecal levobupivacaine and ropivacaine are less potent than bupivacaine. CLINICAL TRIAL REGISTRATION: Chinese Clinical Trial Registry (identifier: ChiCTR-TRC-09000773) and Centre of Clinical Trials Clinical Registry of the Chinese University of Hong Kong (identifier: CUHK_CCT00245).

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Ngan Kee WD, Ng FF, Khaw KS, et al. Dose-Response Curves for Intrathecal Bupivacaine, Levobupivacaine, and Ropivacaine Given for Labor Analgesia in Nulliparous Women. Reg Anesth Pain Med. 2017. PMID: 28991063. doi:10.1097/AAP.0000000000000657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。